Browsing by Author "Aker Vardar, Fügen"
Now showing items 1-3 of 3
-
Clinical importance of discordance in hormone receptor and HER2/NEU status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut (Elsevier, 2014)Aim: Neoadjuvant chemotherapy (NAC) is used longer for both locally advanced breast cancer and early stage to increase breast conservation. Discordance of the hormone receptor (HR) status was reported to be 8-33% of the ... -
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut; Aliustaoglu, Mehmet (Zerbinis Medical Publications, 2014)Purpose: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), ... -
The relationship between positron emission tomography-computed tomography imaging and histopathological features of thyroid incidentalomas detected during follow-up for primary malignancy
Ustaalıoğlu Öven, Başak; Kılıçoğlu, Zeynep Gamze; Bilici, Ahmet Erkan; Tatoǧlu, Mehmet Tarık; Canberk, Şule; Tilki, Metin; Aker Vardar, Fügen (Wolters Kluwer Medknow Publications, 2019)Aim of the Study: While the rate of thyroid incidentaloma detected on positron emission tomography (PET) was reported as 4%, the malignancy rate was 14%u50%. We evaluated the thyroid nodules which were detected by ...
